James T Parsons's most recent trade in Oncolytics Biotech, Inc. was a trade of 10,000 Common Shares done at an average price of $1.0 . Disclosure was reported to the exchange on March 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncolytics Biotech Inc | James T. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 11 Mar 2026 | 10,000 | 41,849 (0%) | 0% | 1.0 | 10,300 | Common Shares |